Subcutaneous Treprostinil
CVT-CV-004
Approved small_molecule terminated
Quick answer
Subcutaneous Treprostinil for Pulmonary Arterial Hypertension is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Pulmonary Arterial Hypertension
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated